ASCO breakthrough
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
ASCO breakthrough
Jun 27, 2024, 02:05 |
Blog
Yan Leyfman: Grateful for an unparalleled experience at ASCO Breakthrough
Yan Leyfman, Internal Medicine and Clinical Researcher at Icahn School of Medicine at Mount Sinai,…
Dec 24, 2023, 09:13 |
Insight
Khalid El Bairi: Happy to share my first interview with ecancer on gender inequity in cancer research during AORTIC23
Khalid El Bairi, Founder of Cancer Biomarkers Working Group, shared on LinkedIn: "Happy to share…
Aug 15, 2023, 16:38 |
Blog
Yan Leyfman: Delighted to meet Dr. Julie Gralow and Dina Michels in person at ASCO Breakthrough 2023.
Quoting Yan Leyfman, a clinical researcher and internal medicine resident at the Icahn School of…
Aug 7, 2023, 07:09 |
Blog
As an Asian American patient advocate, I am trying to raise awareness of care access challenges faced by immigrants groups - Tingting Zhang
As an Asian American patient advocate, I am trying to raise awareness of care access…
All:
4
Posts:
1 - 10
We need to hurry up, because cancer and patients cannot wait!
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Facebook
RSS Feed
Twitter
Linkedin
Youtube